Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bowel cleansing efficacy in elderly patients: 4L PEG vs 2L PEG + ascorbic acid
KCT0004123Phase 4Completed
- Sponsor
- Incheon St. Mary's Hospital
- Start
- Jul 2019
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of macrogol, ascorbic acid, sponsored by Incheon St. Mary's Hospital. Started Jul 2019; status: completed.
02
Drugs
macrogolascorbic acid
Beyond the preview
Go deeper on KCT0004123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004123.